Lung Transplant
66
14
18
29
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.1%
4 terminated out of 66 trials
87.9%
+1.4% vs benchmark
9%
6 trials in Phase 3/4
24%
7 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 29 completed trials
Clinical Trials (66)
GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Protest Trial: TXA vs Saline
Letermovir for CMV Prevention After Lung Transplantation
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
Planned Semi-Elective Lung Tx Study
Tocilizumab in Lung Transplantation
10°C vs 4°C Lung Preservation RCT
Thoracic Specimen Registry
Decreasing Edema With a Novel OCS Solution Trial
A Study of Latin Dance for Post- Lung Transplant
Ultrasound Assessment of Rectus Femoris Cross-sectionnal Area Following Lung Transplantation
US National TOP Registry
TEE and Dysphagia in Lung Transplantation
The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
Bronchial Response to Exercise After Double Lung Transplantation
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates